Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Uremia

3,4-dihydroxyphenylacetic acid has been researched along with Uremia in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohtsuki, S1
Asaba, H1
Takanaga, H1
Deguchi, T1
Hosoya, K1
Otagiri, M1
Terasaki, T1
Al Banchaabouchi, M1
Marescau, B1
D'Hooge, R1
Engelborghs, S1
De Deyn, PP1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Uremia

ArticleYear
Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain.
    Journal of neurochemistry, 2002, Volume: 83, Issue:1

    Topics: Animals; Antimetabolites; Biological Transport; Blood-Brain Barrier; Brain; Capillaries; Cells, Cult

2002
Consequences of renal mass reduction on amino acid and biogenic amine levels in nephrectomized mice.
    Amino acids, 2000, Volume: 18, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Alanine; Amino Acids; Animals; Biogenic Amines; Brain; Citrulline; D

2000